Paraspinal Stimulation in Treating MPS (DIMMST)

October 15, 2012 updated by: Wolnei Caumo, Hospital de Clinicas de Porto Alegre

Paraspinal Stimulation Combined With Trigger Point Needling and Needle Rotation in Treating Myofascial Pain: Randomized Sham-controlled Clinical Trial

To test the hypothesis that the effect of either multiple deep intramuscular stimulation therapy [(DIMMST: trigger point deep dry needling (TrP-DDN) is combined with paraspinal deep intramuscular stimulation (PDIMS) and needle rotation (NR)] would be more effective than a placebo-sham for the treatment of MPS and that DIMMST would be more effective than LTrP-I for improving pain relief, sleep quality, and physical and mental state of the patient.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

75

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: WOLNEI CAUMO, MD, PhD
  • Phone Number: 55-51-3359-8083
  • Email: caumo@cpovo.net

Study Contact Backup

  • Name: CAUMO, MD., PhD
  • Phone Number: 55-51-3359-8083
  • Email: caumo@cpovo.net

Study Locations

    • RS
      • Porto Alegre, RS, Brazil, 90035-003
        • Recruiting
        • Hospital de Clínicas de Porto Alegre
        • Contact:
        • Principal Investigator:
          • Wolnei Caumo, MD., PhD
        • Sub-Investigator:
          • IRACI LS TORRES, PhD
        • Sub-Investigator:
          • FELIPE GREGNI, PhD
      • Porto Alegre, RS, Brazil, 90035-003
        • Recruiting
        • Hospital de Clínicas E Porto Alegre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion criteria

  • Myofascial pain syndrome (MPS) (defined as regional pain, normal neurologic examination, presence of TrPs, taut bands, tender points, and pain characterized as "dull," "achy," or "deep" were relevant to MPS diagnosis. Additionally, palpable nodules, pain that is exacerbated by stress, decreased range of motion, and ropiness in the muscle).
  • Disability in the last three months: (defined if they had one or more these limitation in active and routine activities by MPS : (i) interference with work, (ii) enjoyable activities, (iii) responsibilities at home, (iv) relationships, (v) personal goals, (vi) thinking clearly, and problem solving, concentrating, or remembering during the last three months).
  • Women
  • Age: 19 to 50 years

Exclusion criteria

Rheumatoid arthritis

Fibromyalgia

Previous surgery on the affected areas

Prior experience with acupuncture

Primary radiculopathy

Current use of psychotropic drugs (ilicits

) Habitual use of anti-inflammatory steroids.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Placebo-sham
Placebo-sham twice a week during four weeks
Other Names:
  • Eletroacupuncture
  • Myofascial pain
Active Comparator: Lidocaine injection
Lidocaine 0.2-0.5 mL of 1% injected each time into the trigger point. Twice a week during four weeks
Other Names:
  • Eletroacupuncture
  • Myofascial pain
Experimental: DIMMST

DIMMST include the combination of trigger point deep dry needling (TrP-DDN) is combined with paraspinal deep intramuscular stimulation (PDIMS) and needle rotation (NR).

Twice a week during four weeks

Other Names:
  • Eletroacupuncture
  • Myofascial pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain severity
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
a) The intensity of pain was measured by a 10-cm VAS [30]. VAS scores ranged from no pain (zero) to the worst possible pain (10 cm).
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
Pain threshold
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
Pain pressure threshold (PPT)
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep quality - how did you feel when you woke up
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS:

In general, how did you feel when you woke up?

A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
Sleep quality - compared to your habitual sleep
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS:

Assess the sleep quality of the previous night compared to your habitual sleep?

A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
Sleep quality -last night
Time Frame: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS:

How well did you sleep last night?

A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical and mental Health
Time Frame: Before to begin treatment and after end treatment
Health-related quality of life, assessed at baseline and the end of treatment sessions, was measured with the SF-12 Summary Scales
Before to begin treatment and after end treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Anticipated)

November 1, 2012

Study Completion (Anticipated)

November 1, 2012

Study Registration Dates

First Submitted

October 9, 2012

First Submitted That Met QC Criteria

October 15, 2012

First Posted (Estimate)

October 16, 2012

Study Record Updates

Last Update Posted (Estimate)

October 16, 2012

Last Update Submitted That Met QC Criteria

October 15, 2012

Last Verified

October 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clinical Study - RCT

3
Subscribe